Skip to main content

Table 2 RT-3PE-QTVI parameters in HCM patients versus control group

From: Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging

 

HCM patients (N = 50)

Control group (N = 40)

p value

Ea(cm/sec)

 AS

3.35 ± 1.15

8.14 ± 2.23

< 0.001

 AN

3.58 ± 1.25

8.87 ± 1.81

< 0.001

 AL

4.24 ± 1.50

9.25 ± 1.80

< 0.001

 IL

3.88 ± 1.44

10.26 ± 2.01

< 0.001

 IN

3.51 ± 1.46

9.18 ± 1.57

< 0.001

 IS

3.44 ± 1.42

8.20 ± 1.31

< 0.001

Aa (cm/sec)

 AS

5.12 ± 1.84

6.48 ± 0.87

< 0.001

 AN

5.22 ± 1.20

7.08 ± 0.56

< 0.001

 AL

5.93 ± 1.43

7.21 ± 0.65

< 0.001

 IL

6.02 ± 1.58

7.59 ± 1.13

< 0.001

 IN

5.68 ± 1.46

7.80 ± 1.32

< 0.001

 IS

5.10 ± 1.27

6.63 ± 0.68

< 0.001

E a / Aa

 AS

0.71 ± 0.26

1.27 ± 0.43

< 0.001

 AN

0.69 ± 0.20

1.24 ± 0.18

< 0.001

 AL

0.74 ± 0.28

1.29 ± 0.23

< 0.001

 IL

0.63 ± 0.22

1.45 ± 0.33

< 0.001

 IN

0.63 ± 0.25

1.21 ± 0.29

< 0.001

 IS

0.69 ± 0.18

1.26 ± 0.32

< 0.001

 E/Em ratio

21.47 ± 5.36

10.01 ± 3.94

< 0.001

  1. Ea early diastolic velocity of mitral annulus, Aa late-diastolic velocity of mitral annulus, E mitral inflow peak velocity in early diastole, Em mean value of Ea at six loci in mitral annulus, AS anterior septum, AN anterior wall, AL anterolateral wall, IL inferolateral wall, IN inferior wall, IS inferior septum. Values are expressed as the mean ± SD